The Spatial Biology Company™


Akoya Launches Two New, Fully Optimized PD-1/PD-L1 Panels for Immuno-Oncology Biomarker Analysis of Melanoma and Lung Cancer


As part of our expanding solution for translational immuno-oncology analysis, we’ve launched two new immunofluorescence kits. The Opal™ MOTiF-based kits enable deep tissue profiling of the tumor microenviroment with clinically-relevant biomarkers, including PD-1 and PD-L1, in Melanoma and Lung Cancer samples. These complete staining kits include six ready-to-use primary antibodies, associate staining and assay reagents for automated slide staining and high throughput imaging on the Vectra® Polaris™. We announced the new panels at the 2019 Society for Immunotherapy of Cancer (SITC) annual meeting and presented data at the Akoya workshop and multiple poster presentations. Click here to read the full announcement. An overview of the new panels will be presented in a live webinar on Tuesday, December 17th. Click here to register for the webinar.

Feature Image


  • Fully customizable panels for simultaneous analysis of up to 50 biomarkers
  • Sophisticated software suite for spatial characterization of tissue microenvironment
  • Walk-away automation through seamless integration with existing microscopes
Feature Image


  • Enhanced understanding of the underlying mechanisms leading to disease
  • Unparalleled quantitative multiplex analysis with precise autofluorescence removal
  • One platform harmonizing Opal reagents, multispectral digital pathology & scalable image analysis